Allos terminates AMAG merger agreement with AMAG Allos Therapeutics.

Individually, most Allos’ stockholders voted in favor of the adoption of the Merger Agreement at a special conference of Allos stockholders also kept on October 21, 2011. Related StoriesLiposomal sizing and the Coulter basic principle: an interview with Professor Melvin E. KlegermanExpanded make use of for IntelliCap with further CE Tag for aspiration of liquids’The Panel and shareholders of Allos backed the proposed merger with AMAG based on the strategic rationale, anticipated working synergies and prospect of future growth of the core brands.Methods Research Oversight The study was created by academic investigators belonging to the Head and Neck Disease Administration Group of the Tata Memorial Centre. Data were collected by the scholarly study team and analyzed in collaboration with all the current authors, who attest to the accuracy and completeness of data and evaluation and adherence to the process. The first author prepared the initial draft of the manuscript. All authors contributed to subsequent drafts and made a decision to send the manuscript for publication.